Form 4/A for BHVN Biohaven Ltd.
Accepted 2022-10-12 00:00:00 ET · period of report 2022-10-03 · accession 0001562180-22-007174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-10-12 | 2022-10-03 | BHVN | Heffernan Michael Thomas | Dir | F - Tax | $7.50 | -9,699 | 15.2K | -39% | -$72.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-10-03 | F | D | 9,699 | $7.50 | 15,178 | D | — | — | (F1) These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options. (F2) This amendment is being filed to correct the amount of shares beneficially owned reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that 5,507 shares were withheld by the Issuer in connection with the share settlement to cover the cost of the stock options; however, as reflected in this amendment, 9,699 shares were withheld by the Issuer in connect with the share settlement to cover the cost of the stock options. There were no other changes made to the information in the Original Form 4. |